HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 11-APR-11 3RH3 TITLE CRYSTAL STRUCTURE OF AN UNCHARACTERIZED DUF3829-LIKE PROTEIN (BT_1908) TITLE 2 FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.10 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED DUF3829-LIKE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES THETAIOTAOMICRON; SOURCE 3 ORGANISM_TAXID: 226186; SOURCE 4 STRAIN: VPI-5482; SOURCE 5 GENE: BT_1908; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS ALL ALPHA PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, UNKNOWN KEYWDS 3 FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 3 01-FEB-23 3RH3 1 REMARK SEQADV LINK REVDAT 2 08-NOV-17 3RH3 1 REMARK REVDAT 1 04-MAY-11 3RH3 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN UNCHARACTERIZED DUF3829-LIKE PROTEIN JRNL TITL 2 (BT_1908) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.10 JRNL TITL 3 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30927 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1561 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.17 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2816 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2141 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2671 REMARK 3 BIN R VALUE (WORKING SET) : 0.2122 REMARK 3 BIN FREE R VALUE : 0.2484 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.15 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 145 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3663 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.98950 REMARK 3 B22 (A**2) : 1.39860 REMARK 3 B33 (A**2) : 7.59090 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.70880 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3822 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5166 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1832 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 114 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 563 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3822 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 505 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4675 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|34 - A|289 } REMARK 3 ORIGIN FOR THE GROUP (A): -27.2324 15.3462 72.3961 REMARK 3 T TENSOR REMARK 3 T11: -0.0555 T22: -0.1300 REMARK 3 T33: -0.1490 T12: 0.0319 REMARK 3 T13: 0.0840 T23: 0.0176 REMARK 3 L TENSOR REMARK 3 L11: 0.4966 L22: 1.2715 REMARK 3 L33: 2.2434 L12: 0.3487 REMARK 3 L13: -0.4372 L23: -0.3546 REMARK 3 S TENSOR REMARK 3 S11: 0.0038 S12: 0.1351 S13: 0.0596 REMARK 3 S21: -0.0448 S22: 0.1250 S23: 0.0406 REMARK 3 S31: -0.0953 S32: -0.1869 S33: -0.1288 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|34 - B|289 } REMARK 3 ORIGIN FOR THE GROUP (A): -20.6619 44.0510 50.9284 REMARK 3 T TENSOR REMARK 3 T11: -0.0884 T22: -0.0919 REMARK 3 T33: -0.0879 T12: -0.0258 REMARK 3 T13: 0.0609 T23: -0.0060 REMARK 3 L TENSOR REMARK 3 L11: 0.8783 L22: 1.2084 REMARK 3 L33: 1.1450 L12: -0.0921 REMARK 3 L13: -0.6411 L23: -0.3174 REMARK 3 S TENSOR REMARK 3 S11: -0.0328 S12: -0.0201 S13: -0.0121 REMARK 3 S21: 0.0639 S22: 0.0719 S23: 0.1080 REMARK 3 S31: 0.0765 S32: -0.1291 S33: -0.0391 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. NCS RESTRAINTS WERE APPLIED USING BUSTER'S LSSR REMARK 3 RESTRAINT REPRESENTATION (-AUTONCS). 4. POLYETHYLENE GLYCOL (PEG) REMARK 3 FROM THE CRYSTALLIZATION AND ETHYLENE GLYCOL (EDO) USED AS A REMARK 3 CRYOPROTECTANT HAVE BEEN MODELED INTO THE STRUCTURE. 5.THE REMARK 3 REFINEMENT WAS RESTRAINED AGAINST THE MAD PHASES. REMARK 4 REMARK 4 3RH3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000064923. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91162,0.97934 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE DECEMBER 6, 2010 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31006 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 29.324 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% POLYETHYLENE GLYCOL 3350 0.2M REMARK 280 AMMONIUM CHLORIDE, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.27350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLN A 27 REMARK 465 THR A 28 REMARK 465 VAL A 29 REMARK 465 SER A 30 REMARK 465 SER A 31 REMARK 465 GLU A 32 REMARK 465 SER A 33 REMARK 465 LYS A 75 REMARK 465 VAL A 76 REMARK 465 PRO A 77 REMARK 465 GLU A 78 REMARK 465 VAL A 79 REMARK 465 ASP A 80 REMARK 465 PRO A 81 REMARK 465 ILE A 82 REMARK 465 ALA A 83 REMARK 465 PRO A 84 REMARK 465 PRO A 85 REMARK 465 GLU A 86 REMARK 465 ILE A 87 REMARK 465 ALA A 88 REMARK 465 ALA A 89 REMARK 465 ARG A 90 REMARK 465 ASP A 91 REMARK 465 GLY B 0 REMARK 465 GLN B 27 REMARK 465 THR B 28 REMARK 465 VAL B 29 REMARK 465 SER B 30 REMARK 465 SER B 31 REMARK 465 GLU B 32 REMARK 465 SER B 33 REMARK 465 THR B 73 REMARK 465 GLY B 74 REMARK 465 LYS B 75 REMARK 465 VAL B 76 REMARK 465 PRO B 77 REMARK 465 GLU B 78 REMARK 465 VAL B 79 REMARK 465 ASP B 80 REMARK 465 PRO B 81 REMARK 465 ILE B 82 REMARK 465 ALA B 83 REMARK 465 PRO B 84 REMARK 465 PRO B 85 REMARK 465 GLU B 86 REMARK 465 ILE B 87 REMARK 465 ALA B 88 REMARK 465 ALA B 89 REMARK 465 ARG B 90 REMARK 465 ASP B 91 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 34 OG1 CG2 REMARK 470 GLU A 35 CG CD OE1 OE2 REMARK 470 GLU A 36 CG CD OE1 OE2 REMARK 470 LEU A 37 CG CD1 CD2 REMARK 470 ASP A 38 CG OD1 OD2 REMARK 470 ASP A 39 CG OD1 OD2 REMARK 470 LYS A 42 NZ REMARK 470 ARG A 55 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 GLU A 94 CG CD OE1 OE2 REMARK 470 LEU A 95 CG CD1 CD2 REMARK 470 ASP A 126 CG OD1 OD2 REMARK 470 LYS A 130 CG CD CE NZ REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 LYS A 138 CG CD CE NZ REMARK 470 LYS A 142 CD CE NZ REMARK 470 GLN A 145 CG CD OE1 NE2 REMARK 470 LEU A 147 CG CD1 CD2 REMARK 470 GLU A 149 CG CD OE1 OE2 REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 SER A 169 OG REMARK 470 LYS A 226 CE NZ REMARK 470 LYS A 245 NZ REMARK 470 LYS A 273 CE NZ REMARK 470 SER A 287 OG REMARK 470 VAL A 288 CG1 CG2 REMARK 470 THR B 34 OG1 CG2 REMARK 470 GLU B 35 CG CD OE1 OE2 REMARK 470 GLU B 36 CG CD OE1 OE2 REMARK 470 ASP B 38 CG OD1 OD2 REMARK 470 ASP B 39 CG OD1 OD2 REMARK 470 LYS B 42 CE NZ REMARK 470 ARG B 55 CZ NH1 NH2 REMARK 470 HIS B 56 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 61 CG CD CE NZ REMARK 470 THR B 92 OG1 CG2 REMARK 470 GLU B 94 CG CD OE1 OE2 REMARK 470 LEU B 95 CG CD1 CD2 REMARK 470 LYS B 111 CD CE NZ REMARK 470 LYS B 135 NZ REMARK 470 LYS B 138 CG CD CE NZ REMARK 470 LYS B 152 CD CE NZ REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 GLU B 223 CD OE1 OE2 REMARK 470 LYS B 229 CE NZ REMARK 470 LEU B 244 CG CD1 CD2 REMARK 470 LYS B 245 CE NZ REMARK 470 LYS B 267 CE NZ REMARK 470 LYS B 273 CG CD CE NZ REMARK 470 GLN B 276 CG CD OE1 NE2 REMARK 470 VAL B 288 CG1 CG2 REMARK 470 ILE B 289 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 207 -1.98 -57.48 REMARK 500 ALA A 211 38.41 -161.47 REMARK 500 SER B 207 -1.64 -58.01 REMARK 500 ALA B 211 38.49 -161.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 290 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 294 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 295 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 291 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 293 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 386294 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 27-289 OF THE TARGET REMARK 999 SEQUENCE. DBREF 3RH3 A 27 289 UNP Q8A6H6 Q8A6H6_BACTN 27 289 DBREF 3RH3 B 27 289 UNP Q8A6H6 Q8A6H6_BACTN 27 289 SEQADV 3RH3 GLY A 0 UNP Q8A6H6 EXPRESSION TAG SEQADV 3RH3 GLY B 0 UNP Q8A6H6 EXPRESSION TAG SEQRES 1 A 264 GLY GLN THR VAL SER SER GLU SER THR GLU GLU LEU ASP SEQRES 2 A 264 ASP ALA SER LYS VAL ILE ASN TYR TYR HIS MSE SER LEU SEQRES 3 A 264 ALA VAL LEU ARG HIS VAL ALA ASN ALA LYS ASP ILE ASN SEQRES 4 A 264 ALA VAL LEU GLY TYR MSE GLU GLN THR GLY LYS VAL PRO SEQRES 5 A 264 GLU VAL ASP PRO ILE ALA PRO PRO GLU ILE ALA ALA ARG SEQRES 6 A 264 ASP THR ALA GLU LEU LEU ASP PRO GLY ASP TYR PHE ASN SEQRES 7 A 264 PRO GLU VAL ARG GLN ASN LEU LYS GLN ASN TYR ALA GLY SEQRES 8 A 264 LEU PHE ASN VAL ARG THR GLN PHE TYR ASP ASN PHE ASN SEQRES 9 A 264 LYS PHE LEU ALA TYR LYS LYS SER LYS ASP THR ALA LYS SEQRES 10 A 264 THR ALA GLN LEU LEU ASP GLU ASN TYR LYS LEU SER VAL SEQRES 11 A 264 GLU LEU SER GLU TYR LYS GLN VAL ILE PHE ASP ILE LEU SEQRES 12 A 264 SER PRO LEU THR GLU GLN ALA GLU SER GLU LEU LEU ALA SEQRES 13 A 264 ASP GLU PRO LEU LYS ASP GLN ILE MSE ALA MSE ARG LYS SEQRES 14 A 264 MSE SER GLY THR VAL GLN SER ILE MSE ASN LEU TYR SER SEQRES 15 A 264 ARG LYS HIS ALA MSE ASP GLY VAL ARG ILE ASP LEU LYS SEQRES 16 A 264 MSE ALA GLU LEU GLU LYS GLU LEU LYS ALA ALA GLU LYS SEQRES 17 A 264 ILE PRO ALA VAL THR GLY TYR ASP GLU GLU LEU LYS ASN SEQRES 18 A 264 PHE GLN SER PHE LEU SER THR VAL LYS SER PHE MSE ASN SEQRES 19 A 264 ASP MSE GLN LYS ALA ARG SER LYS GLY ALA TYR SER ASP SEQRES 20 A 264 LYS GLU TYR GLN ALA MSE SER GLU ALA TYR GLU TYR GLY SEQRES 21 A 264 LEU SER VAL ILE SEQRES 1 B 264 GLY GLN THR VAL SER SER GLU SER THR GLU GLU LEU ASP SEQRES 2 B 264 ASP ALA SER LYS VAL ILE ASN TYR TYR HIS MSE SER LEU SEQRES 3 B 264 ALA VAL LEU ARG HIS VAL ALA ASN ALA LYS ASP ILE ASN SEQRES 4 B 264 ALA VAL LEU GLY TYR MSE GLU GLN THR GLY LYS VAL PRO SEQRES 5 B 264 GLU VAL ASP PRO ILE ALA PRO PRO GLU ILE ALA ALA ARG SEQRES 6 B 264 ASP THR ALA GLU LEU LEU ASP PRO GLY ASP TYR PHE ASN SEQRES 7 B 264 PRO GLU VAL ARG GLN ASN LEU LYS GLN ASN TYR ALA GLY SEQRES 8 B 264 LEU PHE ASN VAL ARG THR GLN PHE TYR ASP ASN PHE ASN SEQRES 9 B 264 LYS PHE LEU ALA TYR LYS LYS SER LYS ASP THR ALA LYS SEQRES 10 B 264 THR ALA GLN LEU LEU ASP GLU ASN TYR LYS LEU SER VAL SEQRES 11 B 264 GLU LEU SER GLU TYR LYS GLN VAL ILE PHE ASP ILE LEU SEQRES 12 B 264 SER PRO LEU THR GLU GLN ALA GLU SER GLU LEU LEU ALA SEQRES 13 B 264 ASP GLU PRO LEU LYS ASP GLN ILE MSE ALA MSE ARG LYS SEQRES 14 B 264 MSE SER GLY THR VAL GLN SER ILE MSE ASN LEU TYR SER SEQRES 15 B 264 ARG LYS HIS ALA MSE ASP GLY VAL ARG ILE ASP LEU LYS SEQRES 16 B 264 MSE ALA GLU LEU GLU LYS GLU LEU LYS ALA ALA GLU LYS SEQRES 17 B 264 ILE PRO ALA VAL THR GLY TYR ASP GLU GLU LEU LYS ASN SEQRES 18 B 264 PHE GLN SER PHE LEU SER THR VAL LYS SER PHE MSE ASN SEQRES 19 B 264 ASP MSE GLN LYS ALA ARG SER LYS GLY ALA TYR SER ASP SEQRES 20 B 264 LYS GLU TYR GLN ALA MSE SER GLU ALA TYR GLU TYR GLY SEQRES 21 B 264 LEU SER VAL ILE MODRES 3RH3 MSE A 49 MET SELENOMETHIONINE MODRES 3RH3 MSE A 70 MET SELENOMETHIONINE MODRES 3RH3 MSE A 190 MET SELENOMETHIONINE MODRES 3RH3 MSE A 192 MET SELENOMETHIONINE MODRES 3RH3 MSE A 195 MET SELENOMETHIONINE MODRES 3RH3 MSE A 203 MET SELENOMETHIONINE MODRES 3RH3 MSE A 212 MET SELENOMETHIONINE MODRES 3RH3 MSE A 221 MET SELENOMETHIONINE MODRES 3RH3 MSE A 258 MET SELENOMETHIONINE MODRES 3RH3 MSE A 261 MET SELENOMETHIONINE MODRES 3RH3 MSE A 278 MET SELENOMETHIONINE MODRES 3RH3 MSE B 49 MET SELENOMETHIONINE MODRES 3RH3 MSE B 70 MET SELENOMETHIONINE MODRES 3RH3 MSE B 190 MET SELENOMETHIONINE MODRES 3RH3 MSE B 192 MET SELENOMETHIONINE MODRES 3RH3 MSE B 195 MET SELENOMETHIONINE MODRES 3RH3 MSE B 203 MET SELENOMETHIONINE MODRES 3RH3 MSE B 212 MET SELENOMETHIONINE MODRES 3RH3 MSE B 221 MET SELENOMETHIONINE MODRES 3RH3 MSE B 258 MET SELENOMETHIONINE MODRES 3RH3 MSE B 261 MET SELENOMETHIONINE MODRES 3RH3 MSE B 278 MET SELENOMETHIONINE HET MSE A 49 13 HET MSE A 70 8 HET MSE A 190 13 HET MSE A 192 8 HET MSE A 195 8 HET MSE A 203 8 HET MSE A 212 8 HET MSE A 221 8 HET MSE A 258 8 HET MSE A 261 8 HET MSE A 278 8 HET MSE B 49 13 HET MSE B 70 8 HET MSE B 190 13 HET MSE B 192 8 HET MSE B 195 8 HET MSE B 203 8 HET MSE B 212 8 HET MSE B 221 8 HET MSE B 258 8 HET MSE B 261 8 HET MSE B 278 8 HET PEG A 290 7 HET EDO A 294 4 HET EDO A 295 4 HET EDO B 291 4 HET EDO B 292 4 HET EDO B 293 4 HETNAM MSE SELENOMETHIONINE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 22(C5 H11 N O2 SE) FORMUL 3 PEG C4 H10 O3 FORMUL 4 EDO 5(C2 H6 O2) FORMUL 9 HOH *170(H2 O) HELIX 1 1 THR A 34 ALA A 58 1 25 HELIX 2 2 ASN A 59 GLN A 72 1 14 HELIX 3 3 THR A 92 ASP A 97 5 6 HELIX 4 4 ASN A 103 SER A 137 1 35 HELIX 5 5 ASP A 139 LEU A 180 1 42 HELIX 6 6 LEU A 185 SER A 207 1 23 HELIX 7 7 ASP A 213 LYS A 233 1 21 HELIX 8 8 TYR A 240 SER A 266 1 27 HELIX 9 9 SER A 271 GLU A 283 1 13 HELIX 10 10 THR B 34 ALA B 58 1 25 HELIX 11 11 ASN B 59 GLN B 72 1 14 HELIX 12 12 ALA B 93 ASP B 97 5 5 HELIX 13 13 ASN B 103 SER B 137 1 35 HELIX 14 14 ASP B 139 LEU B 180 1 42 HELIX 15 15 LEU B 185 SER B 207 1 23 HELIX 16 16 ASP B 213 LYS B 233 1 21 HELIX 17 17 TYR B 240 SER B 266 1 27 HELIX 18 18 SER B 271 GLU B 283 1 13 LINK C HIS A 48 N MSE A 49 1555 1555 1.35 LINK C MSE A 49 N SER A 50 1555 1555 1.35 LINK C TYR A 69 N MSE A 70 1555 1555 1.35 LINK C MSE A 70 N GLU A 71 1555 1555 1.34 LINK C ILE A 189 N MSE A 190 1555 1555 1.34 LINK C MSE A 190 N ALA A 191 1555 1555 1.36 LINK C ALA A 191 N MSE A 192 1555 1555 1.34 LINK C MSE A 192 N ARG A 193 1555 1555 1.34 LINK C LYS A 194 N MSE A 195 1555 1555 1.35 LINK C MSE A 195 N SER A 196 1555 1555 1.36 LINK C ILE A 202 N MSE A 203 1555 1555 1.36 LINK C MSE A 203 N ASN A 204 1555 1555 1.33 LINK C ALA A 211 N MSE A 212 1555 1555 1.33 LINK C MSE A 212 N ASP A 213 1555 1555 1.31 LINK C LYS A 220 N MSE A 221 1555 1555 1.33 LINK C MSE A 221 N ALA A 222 1555 1555 1.36 LINK C PHE A 257 N MSE A 258 1555 1555 1.31 LINK C MSE A 258 N ASN A 259 1555 1555 1.35 LINK C ASP A 260 N MSE A 261 1555 1555 1.34 LINK C MSE A 261 N GLN A 262 1555 1555 1.36 LINK C ALA A 277 N MSE A 278 1555 1555 1.34 LINK C MSE A 278 N SER A 279 1555 1555 1.34 LINK C HIS B 48 N MSE B 49 1555 1555 1.35 LINK C MSE B 49 N SER B 50 1555 1555 1.35 LINK C TYR B 69 N MSE B 70 1555 1555 1.34 LINK C MSE B 70 N GLU B 71 1555 1555 1.35 LINK C ILE B 189 N MSE B 190 1555 1555 1.34 LINK C MSE B 190 N ALA B 191 1555 1555 1.35 LINK C ALA B 191 N MSE B 192 1555 1555 1.35 LINK C MSE B 192 N ARG B 193 1555 1555 1.34 LINK C LYS B 194 N MSE B 195 1555 1555 1.36 LINK C MSE B 195 N SER B 196 1555 1555 1.34 LINK C ILE B 202 N MSE B 203 1555 1555 1.36 LINK C MSE B 203 N ASN B 204 1555 1555 1.34 LINK C ALA B 211 N MSE B 212 1555 1555 1.33 LINK C MSE B 212 N ASP B 213 1555 1555 1.30 LINK C LYS B 220 N MSE B 221 1555 1555 1.35 LINK C MSE B 221 N ALA B 222 1555 1555 1.36 LINK C PHE B 257 N MSE B 258 1555 1555 1.31 LINK C MSE B 258 N ASN B 259 1555 1555 1.35 LINK C ASP B 260 N MSE B 261 1555 1555 1.34 LINK C MSE B 261 N GLN B 262 1555 1555 1.34 LINK C ALA B 277 N MSE B 278 1555 1555 1.33 LINK C MSE B 278 N SER B 279 1555 1555 1.34 SITE 1 AC1 4 LYS A 42 GLY A 99 ASP A 100 TYR A 101 SITE 1 AC2 4 GLU A 71 LYS A 209 HIS A 210 TYR A 270 SITE 1 AC3 6 ALA A 58 ILE A 63 SER A 154 SER A 158 SITE 2 AC3 6 LYS A 161 ASN A 204 SITE 1 AC4 5 TYR B 101 PHE B 102 ASN B 103 VAL B 106 SITE 2 AC4 5 LEU B 171 SITE 1 AC5 7 ALA B 58 ILE B 63 SER B 154 SER B 158 SITE 2 AC5 7 LYS B 161 ASN B 204 SER B 207 SITE 1 AC6 3 TYR B 284 GLY B 285 SER B 287 CRYST1 64.409 50.547 87.943 90.00 107.41 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015526 0.000000 0.004868 0.00000 SCALE2 0.000000 0.019784 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011917 0.00000